Clinical Trial Update: Screening for Latent Tuberculosis in Healthcare Workers With Quantiferon-Gold Assay: A Cost-Effectiveness Analysis

View source ↗

Summary

Clinical trial update evaluating the cost-effectiveness of using the QuantiFERON-TB Gold IGRA to screen healthcare workers for latent tuberculosis infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Latent Tuberculosis Infection

Drugs mentioned

• QuantiFERON-TB Gold (Interferon-gamma release assay (IGRA) for latent TB)

Snippet

Sponsor: Assuta Hospital Systems | Conditions: Latent Tuberculosis Infection | Status: UNKNOWN